Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has developed a series of innovative and high performing master mixes designed for manufacturing room-temperature stable molecular diagnostic assays that do not require lyophilization. The conventional […]
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021
CINCINNATI, Jan. 13, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal 2021 financial results Friday, February 5, 2021. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call […]
Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results
CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial results for the first quarter of fiscal 2021. Preliminary First Quarter Fiscal 2021 Results The Company expects first quarter of fiscal 2021 revenue to be approximately $92 million, compared […]
Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
CINCINNATI, Jan. 06, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C. Wainright Bioconnect 2021 Virtual Conference. Jack Kenny, Chief Executive Officer, will pre-record a fireside chat that will be available on January 11, 2021. Jack […]